Lundbeck
HLUN-B.CO
#2091
Rank
โ‚น815.10 B
Marketcap
โ‚น821.55
Share price
-2.27%
Change (1 day)
35.42%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): โ‚น77.12 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น4.03 Billion. In 2025 the company made an earning of โ‚น70.08 Billion, an increase over its 2024 earnings that were of โ‚น51.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น77.12 B10.06%
2025 โ‚น70.08 B36.57%
2024 โ‚น51.31 B25.74%
2023 โ‚น40.81 B21.77%
2022 โ‚น33.51 B31.57%
2021 โ‚น25.47 B-4.61%
2020 โ‚น26.70 B-45.06%
2019 โ‚น48.61 B-34.04%
2018 โ‚น73.70 B12.83%
2017 โ‚น65.31 B93.99%
2016 โ‚น33.67 B-137.28%
2015 -โ‚น90.32 Billion-1246.24%
2014 โ‚น7.87 B-72.36%
2013 โ‚น28.50 B4.38%
2012 โ‚น27.31 B-55.18%
2011 โ‚น60.93 B5.65%
2010 โ‚น57.67 B-5.9%
2009 โ‚น61.29 B